• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Awards Program
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • SPD/PeDRA Journal Club
        • PeDRA Pearls Podcast
        • Mentorship Program
        • 2023 Annual Conference
        • 2023 Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Explore our educational catalog!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • PeDRA EDI Corner
        • View all open funding opportunities!

  • Membership
        • New to PeDRA? Apply Here
        • 2024 Membership Renewal
        • Member Dashboard
  • About
        • Mission, Vision, and Core Values
        • Leadership & Staff
        • Annual Reports & Financials
        • Awards Program
        • News Archive
        • Our Supporters
        • Our Membership
        • Member Spotlight
        • Our Committees
        • Getting to Know You
        • It’s Membership Renewal Time – Renew today!

  • Member Login

Connective Tissue & Autoinflammatory Disorders

Autoimmune connective tissue diseases and other autoinflammatory disorders encompass a spectrum of rare and challenging conditions that frequently present with dermatologic findings, are often associated with systemic comorbidities, and can have a tremendous impact on quality of life. These diseases rarely have FDA-approved therapies.

Goals of the Connective Tissue & Autoinflammatory Disorders Focused Study Group include improving our understanding of the pathogenesis, prognosis, and comorbidities of these conditions, identifying more reliable monitoring tools, and advancing therapeutic options for our patients.

The Connective Tissue Disease Focused Study Group at work, October 2021.

Chair

The Connective Tissue & Autoinflammatory Focused Study Group is co-chaired by Heather Brandling-Bennett, MD at the University of Washington and Maria Teresa Garcia Romero, MD at the National Institute of Pediatrics, Mexico City.

Links

Studies
  • Characterization of non-coding genetic loci and transcription factors that drive development of linear morphea
  • Characterization of the presenting cutaneous manifestations of juvenile dermatomyositis
  • Characterization of the presenting cutaneous manifestations of juvenile dermatomyositis
  • Developing an Outcome Measure for Morphea Disease Activity
  • Genetic Variations in Non-coding Regulatory Regions in Linear Morphea
Studies Seeking Collaborators

Coming soon.

Publications

Siegfried, Elaine, et al. “Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines” Pediatric Dermatology (2023).

Ng, Ashley, et al. “Presenting characteristics and progression of pediatric-onset morphea: Interim analysis of a prospective registry” Pediatric Dermatology (2023).

Chen, Henry, et al. “Clinical characteristics associated with musculoskeletal extracutaneous manifestations in pediatric and adult morphea: a prospective, cohort study” Journal of Investigative Dermatology (2023).

García-Romero, Maria Teresa, et al. “Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea” JAMA Dermatology (2023).

Ezeh, Nnenna, et al. “Cross-Sectional Characteristics of Pediatric-Onset Discoid Lupus Erythematosus: Results of a Multicenter, Retrospective Cohort Study” Journal of the American Academy of Dermatology (2022).

Ramien, Michele, et al. “Blistering severe cutaneous adverse reactions in children: Proposal for pediatric-focused clinical criteria” British Journal of Dermatology (2021).

Chiu, Yvonne, et al. “Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations” Journal of the American Academy of Dermatology (2021).

Reynolds, Sean, et al. “Systemic Immunosuppressive Therapy for Inflammatory Skin Diseases in Children: Expert-Consensus-Based Guidance for Clinical Decision Making During the COVID-19 Pandemic” Pediatric Dermatology (2020).

Arkin, Lisa, et al. “Practice-Based Differences in Pediatric Discoid Lupus Erythmatosus.” British Journal of Dermatology (2019).

Resources

Resources for Researchers

CTD Virtual Education

Active Member Locations

Get involved!

Send us an email to get connected to the CTD group or to learn more.

Email PeDRA

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sign up to receive emails from PeDRA

Four Star Charity Navigator

Join PeDRA
Donate

Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are comfortable with this.OKPrivacy policy